Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by symbiont of host defense response (GO:0052509) | 4.19915001 |
2 | modulation by symbiont of host defense response (GO:0052031) | 4.19915001 |
3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.19915001 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.19915001 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.19915001 |
6 | modulation by symbiont of host immune response (GO:0052553) | 4.19915001 |
7 | negative regulation of interleukin-12 production (GO:0032695) | 4.19622985 |
8 | dosage compensation (GO:0007549) | 4.14419798 |
9 | cellular extravasation (GO:0045123) | 4.12486699 |
10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.07501498 |
11 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.03757910 |
12 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.97147162 |
13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81725493 |
14 | negative regulation of histone methylation (GO:0031061) | 3.79518623 |
15 | activated T cell proliferation (GO:0050798) | 3.76241512 |
16 | macrophage activation involved in immune response (GO:0002281) | 3.75239433 |
17 | nuclear pore complex assembly (GO:0051292) | 3.63337586 |
18 | negative regulation of cell killing (GO:0031342) | 3.61420857 |
19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61420857 |
20 | response to peptidoglycan (GO:0032494) | 3.52240346 |
21 | protein localization to kinetochore (GO:0034501) | 3.39266110 |
22 | detection of other organism (GO:0098543) | 3.33567074 |
23 | histone H2A acetylation (GO:0043968) | 3.33163285 |
24 | neutrophil activation involved in immune response (GO:0002283) | 3.32674377 |
25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32113382 |
26 | mitotic nuclear envelope disassembly (GO:0007077) | 3.31553342 |
27 | tolerance induction (GO:0002507) | 3.31215292 |
28 | negative regulation of gene expression, epigenetic (GO:0045814) | 3.30481939 |
29 | immunoglobulin mediated immune response (GO:0016064) | 3.24035075 |
30 | response to muramyl dipeptide (GO:0032495) | 3.22941276 |
31 | detection of bacterium (GO:0016045) | 3.22247294 |
32 | negative T cell selection (GO:0043383) | 3.22092455 |
33 | nuclear pore organization (GO:0006999) | 3.21412635 |
34 | protein localization to chromosome, centromeric region (GO:0071459) | 3.20853329 |
35 | actin nucleation (GO:0045010) | 3.19498659 |
36 | myeloid cell activation involved in immune response (GO:0002275) | 3.19423569 |
37 | nuclear envelope disassembly (GO:0051081) | 3.19305765 |
38 | membrane disassembly (GO:0030397) | 3.19305765 |
39 | microglial cell activation (GO:0001774) | 3.16773227 |
40 | defense response to protozoan (GO:0042832) | 3.16318705 |
41 | response to interleukin-15 (GO:0070672) | 3.15603560 |
42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.15384784 |
43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.14611416 |
44 | mitotic chromosome condensation (GO:0007076) | 3.14541252 |
45 | leukocyte aggregation (GO:0070486) | 3.14379677 |
46 | response to type I interferon (GO:0034340) | 3.13601639 |
47 | negative thymic T cell selection (GO:0045060) | 3.12693463 |
48 | regulation of mast cell activation (GO:0033003) | 3.12592268 |
49 | regulation of antigen processing and presentation (GO:0002577) | 3.11756586 |
50 | response to protozoan (GO:0001562) | 3.08486459 |
51 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07627418 |
52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06377836 |
53 | cellular response to interleukin-15 (GO:0071350) | 3.05526709 |
54 | type I interferon signaling pathway (GO:0060337) | 3.04381302 |
55 | cellular response to type I interferon (GO:0071357) | 3.04381302 |
56 | regulation of histone H3-K9 methylation (GO:0051570) | 3.03027515 |
57 | pore complex assembly (GO:0046931) | 3.03004376 |
58 | positive thymic T cell selection (GO:0045059) | 3.02082643 |
59 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01454917 |
60 | regulation of mast cell degranulation (GO:0043304) | 3.01062807 |
61 | negative regulation of interleukin-6 production (GO:0032715) | 2.97790021 |
62 | histone H3-K36 demethylation (GO:0070544) | 2.93868875 |
63 | respiratory burst (GO:0045730) | 2.92936771 |
64 | mast cell activation (GO:0045576) | 2.92716733 |
65 | B cell receptor signaling pathway (GO:0050853) | 2.92593449 |
66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90651130 |
67 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.90199109 |
68 | neutrophil activation (GO:0042119) | 2.90100532 |
69 | histone H3-K4 trimethylation (GO:0080182) | 2.89529074 |
70 | regulation of B cell differentiation (GO:0045577) | 2.89448845 |
71 | protein-DNA complex disassembly (GO:0032986) | 2.89031744 |
72 | nucleosome disassembly (GO:0006337) | 2.89031744 |
73 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88776271 |
74 | sister chromatid segregation (GO:0000819) | 2.87701091 |
75 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87396254 |
76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85436771 |
77 | positive regulation of mast cell activation (GO:0033005) | 2.84929045 |
78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84732733 |
79 | leukocyte degranulation (GO:0043299) | 2.84705270 |
80 | negative regulation of interleukin-1 production (GO:0032692) | 2.84408372 |
81 | regulation of chromatin binding (GO:0035561) | 2.84403076 |
82 | nuclear envelope organization (GO:0006998) | 2.83752632 |
83 | macrophage activation (GO:0042116) | 2.83530616 |
84 | mannose metabolic process (GO:0006013) | 2.79534151 |
85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.79150775 |
86 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78882565 |
87 | neutrophil mediated immunity (GO:0002446) | 2.78731487 |
88 | granulocyte activation (GO:0036230) | 2.78521654 |
89 | germinal center formation (GO:0002467) | 2.77261554 |
90 | detection of external biotic stimulus (GO:0098581) | 2.76619257 |
91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75954654 |
92 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75836849 |
93 | response to host immune response (GO:0052572) | 2.75836849 |
94 | regulation of T cell tolerance induction (GO:0002664) | 2.75348801 |
95 | positive regulation of chromosome segregation (GO:0051984) | 2.74414976 |
96 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.74393162 |
97 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73608096 |
98 | positive regulation of defense response to virus by host (GO:0002230) | 2.71555437 |
99 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.71235908 |
100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70670506 |
101 | regulation of RNA export from nucleus (GO:0046831) | 2.69967143 |
102 | pre-miRNA processing (GO:0031054) | 2.69690375 |
103 | thymic T cell selection (GO:0045061) | 2.68536681 |
104 | regulation of tolerance induction (GO:0002643) | 2.68062616 |
105 | mitotic sister chromatid segregation (GO:0000070) | 2.67855761 |
106 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.67756436 |
107 | mast cell degranulation (GO:0043303) | 2.66581542 |
108 | mast cell activation involved in immune response (GO:0002279) | 2.66581542 |
109 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.65880849 |
110 | mitotic sister chromatid cohesion (GO:0007064) | 2.65371556 |
111 | V(D)J recombination (GO:0033151) | 2.64880268 |
112 | histone H2A monoubiquitination (GO:0035518) | 2.64820259 |
113 | positive regulation of granulocyte differentiation (GO:0030854) | 2.64590825 |
114 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.64208750 |
115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.64208750 |
116 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.63530300 |
117 | mitotic cytokinesis (GO:0000281) | 2.63518748 |
118 | T cell selection (GO:0045058) | 2.62018909 |
119 | detection of biotic stimulus (GO:0009595) | 2.61631843 |
120 | detection of molecule of bacterial origin (GO:0032490) | 2.61454714 |
121 | histone H3-K4 methylation (GO:0051568) | 2.60559588 |
122 | negative regulation of innate immune response (GO:0045824) | 2.59848168 |
123 | positive T cell selection (GO:0043368) | 2.59572209 |
124 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.59488379 |
125 | protein localization to chromosome (GO:0034502) | 2.59487843 |
126 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59170660 |
127 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.57585656 |
128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.57585656 |
129 | regulation of sister chromatid cohesion (GO:0007063) | 2.57543599 |
130 | DNA unwinding involved in DNA replication (GO:0006268) | 2.56984959 |
131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.56891161 |
132 | regulation of interleukin-12 production (GO:0032655) | 2.56832045 |
133 | gene silencing by RNA (GO:0031047) | 2.56140556 |
134 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.55595108 |
135 | regulation of protein heterodimerization activity (GO:0043497) | 2.54095094 |
136 | translesion synthesis (GO:0019985) | 2.52954381 |
137 | T cell migration (GO:0072678) | 2.52882883 |
138 | histone H3-K9 demethylation (GO:0033169) | 2.50718970 |
139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.49666761 |
140 | establishment of chromosome localization (GO:0051303) | 2.48417156 |
141 | regulation of chromosome segregation (GO:0051983) | 2.47619993 |
142 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47340617 |
143 | DNA geometric change (GO:0032392) | 2.45331333 |
144 | sequestering of actin monomers (GO:0042989) | 2.44885495 |
145 | B cell homeostasis (GO:0001782) | 2.44866857 |
146 | DNA duplex unwinding (GO:0032508) | 2.44269474 |
147 | interferon-gamma secretion (GO:0072643) | 2.43224307 |
148 | gene silencing (GO:0016458) | 2.42589868 |
149 | positive regulation of B cell differentiation (GO:0045579) | 2.42204173 |
150 | regulation of histone methylation (GO:0031060) | 2.41864497 |
151 | snRNA processing (GO:0016180) | 2.41862809 |
152 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.41627098 |
153 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.41093257 |
154 | RNA stabilization (GO:0043489) | 2.40508302 |
155 | mRNA stabilization (GO:0048255) | 2.40508302 |
156 | histone H4 acetylation (GO:0043967) | 2.39484152 |
157 | regulation of spindle organization (GO:0090224) | 2.39352275 |
158 | histone lysine demethylation (GO:0070076) | 2.37694481 |
159 | T cell costimulation (GO:0031295) | 2.37181295 |
160 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.35402618 |
161 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.35402618 |
162 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.35402618 |
163 | DNA demethylation (GO:0080111) | 2.35328399 |
164 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.34426318 |
165 | mitotic metaphase plate congression (GO:0007080) | 2.33998371 |
166 | DNA strand elongation (GO:0022616) | 2.33758805 |
167 | regulation of histone H3-K27 methylation (GO:0061085) | 2.29736186 |
168 | lymphocyte costimulation (GO:0031294) | 2.29437831 |
169 | negative regulation of histone modification (GO:0031057) | 2.29184254 |
170 | localization within membrane (GO:0051668) | 2.29147517 |
171 | RNA localization (GO:0006403) | 2.29104505 |
172 | histone demethylation (GO:0016577) | 2.28904360 |
173 | negative regulation of chromatin modification (GO:1903309) | 2.28886076 |
174 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.28256072 |
175 | interferon-gamma production (GO:0032609) | 2.27683126 |
176 | regulation of DNA damage checkpoint (GO:2000001) | 2.27461654 |
177 | regulation of translational termination (GO:0006449) | 2.27286990 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.06351500 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.37958379 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95496880 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.50511789 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.32402467 |
6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.79697606 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.77233370 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.71897897 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35390428 |
10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30269568 |
11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26825374 |
12 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.26582459 |
13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22939427 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20284691 |
15 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.19973735 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19769983 |
17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.16972125 |
18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.15223676 |
19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12376930 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03882431 |
21 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00082391 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 1.97282246 |
23 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96509749 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87698682 |
25 | * MAF_26560356_Chip-Seq_TH1_Human | 1.87132305 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83179064 |
27 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.81026769 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78066343 |
29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77598332 |
30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.73749534 |
31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.73119307 |
32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72686460 |
33 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71109920 |
34 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.67654762 |
35 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66185569 |
36 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.65177531 |
37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64781998 |
38 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.63864197 |
39 | MYB_26560356_Chip-Seq_TH1_Human | 1.61795200 |
40 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61174674 |
41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59154815 |
42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55571274 |
43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54776292 |
44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.54423926 |
45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.52785823 |
46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51982047 |
47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50858116 |
48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50602257 |
49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49406063 |
50 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46994666 |
51 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.46954637 |
52 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46875427 |
53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.46470500 |
54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46026396 |
55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.45488387 |
56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44937671 |
57 | MAF_26560356_Chip-Seq_TH2_Human | 1.44148797 |
58 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.43698922 |
59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43296109 |
60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43248351 |
61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.41288855 |
62 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.41254266 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40983119 |
64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39143358 |
65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.38042565 |
66 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.37466699 |
67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37348932 |
68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35247654 |
69 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35195804 |
70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35078238 |
71 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35021924 |
72 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34863043 |
73 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.34134078 |
74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33970152 |
75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32973171 |
76 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.32225313 |
77 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31151583 |
78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30095605 |
79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29129414 |
80 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.26457409 |
81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25931415 |
82 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25649448 |
83 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24573307 |
84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.24268644 |
85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23059868 |
86 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22536145 |
87 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21817197 |
88 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21773743 |
89 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20542152 |
90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19799476 |
91 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.18328933 |
92 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17798390 |
93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17558948 |
94 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17406373 |
95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.17084542 |
96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17000296 |
97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16628364 |
98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16065621 |
99 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15050752 |
100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15011510 |
101 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14667545 |
102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12793272 |
103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11031253 |
104 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09437669 |
105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08373320 |
106 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08286313 |
107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07449501 |
108 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.06952040 |
109 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06332645 |
110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05965772 |
111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05495500 |
112 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.03276541 |
113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02904128 |
114 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.02704483 |
115 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01800428 |
116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01434945 |
117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00234220 |
118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00176396 |
119 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99803806 |
120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99631965 |
121 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.98547151 |
122 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98514776 |
123 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.98434717 |
124 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.97701518 |
125 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97582080 |
126 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97278997 |
127 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.96636597 |
128 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95448045 |
129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95415932 |
130 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.95264488 |
131 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95109122 |
132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94048258 |
133 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91680638 |
134 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91226778 |
135 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90060933 |
136 | P300_27268052_Chip-Seq_Bcells_Human | 0.89905187 |
137 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.89532835 |
138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89508019 |
139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89055630 |
140 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87752257 |
141 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87543039 |
142 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85822784 |
143 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85642425 |
144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85436765 |
145 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85011699 |
146 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84770713 |
147 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84196050 |
148 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82436800 |
149 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81780791 |
150 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.80810544 |
151 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80441295 |
152 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.79859378 |
153 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.79575975 |
154 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.77776815 |
155 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.77203288 |
156 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76225687 |
157 | P68_20966046_ChIP-Seq_HELA_Human | 0.75726954 |
158 | BCL6_25482012_ChIP-Seq_CML-JURL-MK1_Human | 0.75425016 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 3.81768000 |
2 | MP0000569_abnormal_digit_pigmentation | 3.18456230 |
3 | MP0003693_abnormal_embryo_hatching | 3.13853048 |
4 | MP0003111_abnormal_nucleus_morphology | 3.07054167 |
5 | MP0006082_CNS_inflammation | 2.75466136 |
6 | MP0001835_abnormal_antigen_presentation | 2.72195318 |
7 | MP0003763_abnormal_thymus_physiology | 2.69466646 |
8 | * MP0003077_abnormal_cell_cycle | 2.58199437 |
9 | * MP0010094_abnormal_chromosome_stability | 2.57334774 |
10 | MP0003303_peritoneal_inflammation | 2.43697285 |
11 | MP0005076_abnormal_cell_differentiation | 2.31139692 |
12 | MP0001800_abnormal_humoral_immune | 2.28705243 |
13 | MP0005671_abnormal_response_to | 2.26334780 |
14 | MP0010352_gastrointestinal_tract_polyps | 2.24744874 |
15 | MP0002398_abnormal_bone_marrow | 2.22937774 |
16 | MP0008057_abnormal_DNA_replication | 2.08638756 |
17 | MP0003436_decreased_susceptibility_to | 2.06505949 |
18 | MP0004957_abnormal_blastocyst_morpholog | 2.05615319 |
19 | MP0000685_abnormal_immune_system | 2.02366076 |
20 | MP0002452_abnormal_antigen_presenting | 1.96844509 |
21 | MP0002420_abnormal_adaptive_immunity | 1.95446150 |
22 | MP0002254_reproductive_system_inflammat | 1.95140570 |
23 | MP0008058_abnormal_DNA_repair | 1.94432687 |
24 | MP0001819_abnormal_immune_cell | 1.93821581 |
25 | MP0001730_embryonic_growth_arrest | 1.90169382 |
26 | MP0000703_abnormal_thymus_morphology | 1.84153545 |
27 | MP0000716_abnormal_immune_system | 1.82027828 |
28 | MP0001790_abnormal_immune_system | 1.81426325 |
29 | MP0005387_immune_system_phenotype | 1.81426325 |
30 | MP0004381_abnormal_hair_follicle | 1.80780435 |
31 | MP0009764_decreased_sensitivity_to | 1.76245188 |
32 | MP0005000_abnormal_immune_tolerance | 1.74837700 |
33 | MP0009333_abnormal_splenocyte_physiolog | 1.74778848 |
34 | MP0002723_abnormal_immune_serum | 1.73502112 |
35 | MP0000350_abnormal_cell_proliferation | 1.72848546 |
36 | MP0003121_genomic_imprinting | 1.72832745 |
37 | MP0005058_abnormal_lysosome_morphology | 1.71499471 |
38 | MP0000490_abnormal_crypts_of | 1.71273291 |
39 | MP0002722_abnormal_immune_system | 1.69995887 |
40 | MP0002138_abnormal_hepatobiliary_system | 1.69854514 |
41 | MP0008007_abnormal_cellular_replicative | 1.66833659 |
42 | MP0002396_abnormal_hematopoietic_system | 1.64904424 |
43 | MP0000689_abnormal_spleen_morphology | 1.64114419 |
44 | MP0002166_altered_tumor_susceptibility | 1.59524168 |
45 | MP0010307_abnormal_tumor_latency | 1.57700827 |
46 | MP0002429_abnormal_blood_cell | 1.57403189 |
47 | MP0004808_abnormal_hematopoietic_stem | 1.56477204 |
48 | MP0009840_abnormal_foam_cell | 1.52580406 |
49 | MP0005025_abnormal_response_to | 1.49721519 |
50 | MP0002405_respiratory_system_inflammati | 1.44418732 |
51 | MP0002419_abnormal_innate_immunity | 1.38398678 |
52 | MP0005167_abnormal_blood-brain_barrier | 1.37852523 |
53 | MP0002998_abnormal_bone_remodeling | 1.36874924 |
54 | MP0001873_stomach_inflammation | 1.35321288 |
55 | MP0003300_gastrointestinal_ulcer | 1.35217876 |
56 | MP0008469_abnormal_protein_level | 1.32087178 |
57 | * MP0002019_abnormal_tumor_incidence | 1.31889712 |
58 | MP0000465_gastrointestinal_hemorrhage | 1.31857850 |
59 | MP0009278_abnormal_bone_marrow | 1.29807516 |
60 | MP0002006_tumorigenesis | 1.29391373 |
61 | MP0001697_abnormal_embryo_size | 1.27798227 |
62 | MP0010155_abnormal_intestine_physiology | 1.25784292 |
63 | MP0004947_skin_inflammation | 1.24983075 |
64 | MP0004510_myositis | 1.24137991 |
65 | MP0009785_altered_susceptibility_to | 1.23031226 |
66 | MP0005075_abnormal_melanosome_morpholog | 1.22462141 |
67 | MP0005310_abnormal_salivary_gland | 1.21598743 |
68 | MP0002080_prenatal_lethality | 1.20994250 |
69 | MP0000313_abnormal_cell_death | 1.20523845 |
70 | MP0002084_abnormal_developmental_patter | 1.18329589 |
71 | MP0005451_abnormal_body_composition | 1.12800922 |
72 | MP0003172_abnormal_lysosome_physiology | 1.11989659 |
73 | MP0003890_abnormal_embryonic-extraembry | 1.11940307 |
74 | MP0003448_altered_tumor_morphology | 1.11364636 |
75 | MP0001672_abnormal_embryogenesis/_devel | 1.11112632 |
76 | MP0005380_embryogenesis_phenotype | 1.11112632 |
77 | MP0003123_paternal_imprinting | 1.09651002 |
78 | MP0002085_abnormal_embryonic_tissue | 1.08836267 |
79 | MP0001663_abnormal_digestive_system | 1.08551565 |
80 | MP0003646_muscle_fatigue | 1.08486781 |
81 | MP0008877_abnormal_DNA_methylation | 1.07978690 |
82 | MP0002132_abnormal_respiratory_system | 1.07788843 |
83 | MP0008004_abnormal_stomach_pH | 1.07686612 |
84 | MP0005621_abnormal_cell_physiology | 1.07677569 |
85 | MP0002933_joint_inflammation | 1.07289200 |
86 | MP0008961_abnormal_basal_metabolism | 1.06583974 |
87 | MP0002086_abnormal_extraembryonic_tissu | 1.04986676 |
88 | MP0003566_abnormal_cell_adhesion | 1.04592994 |
89 | MP0003984_embryonic_growth_retardation | 1.04400631 |
90 | MP0005397_hematopoietic_system_phenotyp | 1.03694609 |
91 | MP0001545_abnormal_hematopoietic_system | 1.03694609 |
92 | MP0001849_ear_inflammation | 1.03656632 |
93 | MP0003828_pulmonary_edema | 1.03315929 |
94 | MP0002088_abnormal_embryonic_growth/wei | 1.02083062 |
95 | MP0004197_abnormal_fetal_growth/weight/ | 1.01594226 |
96 | MP0005384_cellular_phenotype | 1.00667246 |
97 | MP0003866_abnormal_defecation | 1.00617375 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.98610116 |
99 | MP0005174_abnormal_tail_pigmentation | 0.97392423 |
100 | MP0000733_abnormal_muscle_development | 0.96920413 |
101 | MP0008932_abnormal_embryonic_tissue | 0.95191109 |
102 | MP0005464_abnormal_platelet_physiology | 0.94737832 |
103 | MP0000858_altered_metastatic_potential | 0.94166198 |
104 | MP0001929_abnormal_gametogenesis | 0.93882980 |
105 | MP0001915_intracranial_hemorrhage | 0.92653634 |
106 | MP0001845_abnormal_inflammatory_respons | 0.89886466 |
107 | MP0001986_abnormal_taste_sensitivity | 0.89325005 |
108 | MP0002148_abnormal_hypersensitivity_rea | 0.87324674 |
109 | MP0005023_abnormal_wound_healing | 0.86307241 |
110 | MP0002693_abnormal_pancreas_physiology | 0.85835391 |
111 | MP0004883_abnormal_blood_vessel | 0.85811983 |
112 | MP0000371_diluted_coat_color | 0.83836729 |
113 | MP0000604_amyloidosis | 0.83416972 |
114 | MP0003786_premature_aging | 0.81630657 |
115 | MP0000537_abnormal_urethra_morphology | 0.80046090 |
116 | MP0002653_abnormal_ependyma_morphology | 0.79461122 |
117 | MP0001851_eye_inflammation | 0.78389268 |
118 | MP0002210_abnormal_sex_determination | 0.77872623 |
119 | MP0003045_fibrosis | 0.76907431 |
120 | MP0004133_heterotaxia | 0.76246805 |
121 | MP0001501_abnormal_sleep_pattern | 0.75435254 |
122 | MP0003698_abnormal_male_reproductive | 0.75118249 |
123 | MP0008260_abnormal_autophagy | 0.73342073 |
124 | MP0001533_abnormal_skeleton_physiology | 0.71368405 |
125 | MP0004130_abnormal_muscle_cell | 0.70997340 |
126 | MP0003183_abnormal_peptide_metabolism | 0.70931621 |
127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69907931 |
128 | MP0000015_abnormal_ear_pigmentation | 0.69905706 |
129 | MP0001145_abnormal_male_reproductive | 0.69545671 |
130 | MP0005390_skeleton_phenotype | 0.69446029 |
131 | MP0003656_abnormal_erythrocyte_physiolo | 0.67469312 |
132 | MP0003191_abnormal_cellular_cholesterol | 0.65516602 |
133 | MP0001853_heart_inflammation | 0.64736686 |
134 | MP0000249_abnormal_blood_vessel | 0.64629063 |
135 | MP0009765_abnormal_xenobiotic_induced | 0.64120750 |
136 | MP0009763_increased_sensitivity_to | 0.60171462 |
137 | MP0000343_altered_response_to | 0.59221167 |
138 | MP0005164_abnormal_response_to | 0.58852177 |
139 | MP0000470_abnormal_stomach_morphology | 0.58668809 |
140 | MP0005166_decreased_susceptibility_to | 0.57977186 |
141 | MP0003690_abnormal_glial_cell | 0.57742165 |
142 | MP0003195_calcinosis | 0.57727979 |
143 | MP0005381_digestive/alimentary_phenotyp | 0.56761522 |
144 | MP0009115_abnormal_fat_cell | 0.55687165 |
145 | MP0003075_altered_response_to | 0.55488598 |
146 | MP0003795_abnormal_bone_structure | 0.54665911 |
147 | MP0002332_abnormal_exercise_endurance | 0.52102093 |
148 | MP0003787_abnormal_imprinting | 0.51493190 |
149 | MP0002136_abnormal_kidney_physiology | 0.49184613 |
150 | MP0008872_abnormal_physiological_respon | 0.48973167 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 5.48418767 |
2 | Myositis (HP:0100614) | 4.73271866 |
3 | Optic neuritis (HP:0100653) | 4.48715406 |
4 | Retrobulbar optic neuritis (HP:0100654) | 4.48715406 |
5 | Orchitis (HP:0100796) | 4.36913253 |
6 | Abnormality of macrophages (HP:0004311) | 4.07988743 |
7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84237972 |
8 | Increased cerebral lipofuscin (HP:0011813) | 3.82778445 |
9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.74135166 |
10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60422765 |
11 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60422765 |
12 | Abnormality of the fingertips (HP:0001211) | 3.51771190 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.32821925 |
14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.32821925 |
15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.32821925 |
16 | Abnormality of the anterior horn cell (HP:0006802) | 3.32491962 |
17 | Degeneration of anterior horn cells (HP:0002398) | 3.32491962 |
18 | Hyperacusis (HP:0010780) | 3.31167011 |
19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.28360221 |
20 | Recurrent viral infections (HP:0004429) | 3.23830981 |
21 | Recurrent skin infections (HP:0001581) | 3.23205423 |
22 | Gastrointestinal infarctions (HP:0005244) | 3.19051164 |
23 | Hemoptysis (HP:0002105) | 3.14565916 |
24 | Encephalitis (HP:0002383) | 3.14265050 |
25 | Recurrent abscess formation (HP:0002722) | 3.12890311 |
26 | Keratoconjunctivitis sicca (HP:0001097) | 3.04493644 |
27 | Keratoconjunctivitis (HP:0001096) | 3.03191441 |
28 | Vasculitis (HP:0002633) | 3.02985262 |
29 | T lymphocytopenia (HP:0005403) | 2.99122379 |
30 | Spontaneous hematomas (HP:0007420) | 2.95540784 |
31 | Pustule (HP:0200039) | 2.95384540 |
32 | Pulmonary infiltrates (HP:0002113) | 2.94819343 |
33 | Abnormality of T cell number (HP:0011839) | 2.87696422 |
34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87382117 |
35 | Recurrent bronchitis (HP:0002837) | 2.74845598 |
36 | Recurrent bacterial skin infections (HP:0005406) | 2.71599634 |
37 | Hematochezia (HP:0002573) | 2.71567837 |
38 | Eczematoid dermatitis (HP:0000976) | 2.70314832 |
39 | Clumsiness (HP:0002312) | 2.70146702 |
40 | Recurrent fungal infections (HP:0002841) | 2.69239016 |
41 | Vacuolated lymphocytes (HP:0001922) | 2.68594783 |
42 | Increased IgE level (HP:0003212) | 2.65470894 |
43 | Inflammation of the large intestine (HP:0002037) | 2.58636559 |
44 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.58478405 |
45 | Cellulitis (HP:0100658) | 2.54295741 |
46 | Colitis (HP:0002583) | 2.54256736 |
47 | Combined immunodeficiency (HP:0005387) | 2.53813619 |
48 | Gingivitis (HP:0000230) | 2.49469388 |
49 | Ependymoma (HP:0002888) | 2.48953949 |
50 | Panhypogammaglobulinemia (HP:0003139) | 2.48410124 |
51 | Cortical dysplasia (HP:0002539) | 2.42327422 |
52 | Prolonged bleeding time (HP:0003010) | 2.41545213 |
53 | Gastrointestinal inflammation (HP:0004386) | 2.41388113 |
54 | Abnormality of the astrocytes (HP:0100707) | 2.40483103 |
55 | Astrocytoma (HP:0009592) | 2.40483103 |
56 | Episodic fever (HP:0001954) | 2.39772557 |
57 | Protruding tongue (HP:0010808) | 2.38596380 |
58 | Severe combined immunodeficiency (HP:0004430) | 2.37213355 |
59 | Heterotopia (HP:0002282) | 2.35530383 |
60 | Dysostosis multiplex (HP:0000943) | 2.34227137 |
61 | Abnormality of T cells (HP:0002843) | 2.33953904 |
62 | Personality changes (HP:0000751) | 2.32858900 |
63 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32566094 |
64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.32084576 |
65 | Agammaglobulinemia (HP:0004432) | 2.30339135 |
66 | Abnormality of the columella (HP:0009929) | 2.30060146 |
67 | Arterial thrombosis (HP:0004420) | 2.29387121 |
68 | Increased nuchal translucency (HP:0010880) | 2.24412658 |
69 | B lymphocytopenia (HP:0010976) | 2.24025981 |
70 | Abnormality of B cell number (HP:0010975) | 2.24025981 |
71 | Hypochromic anemia (HP:0001931) | 2.23290110 |
72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22960633 |
73 | Lymphopenia (HP:0001888) | 2.22292985 |
74 | Abnormality of T cell physiology (HP:0011840) | 2.21885923 |
75 | IgM deficiency (HP:0002850) | 2.21697201 |
76 | Urticaria (HP:0001025) | 2.20395529 |
77 | Amyotrophic lateral sclerosis (HP:0007354) | 2.17769511 |
78 | Pulmonary embolism (HP:0002204) | 2.16640810 |
79 | Volvulus (HP:0002580) | 2.15947343 |
80 | Poikiloderma (HP:0001029) | 2.15281015 |
81 | Abnormality of DNA repair (HP:0003254) | 2.13623321 |
82 | Meningitis (HP:0001287) | 2.13037231 |
83 | Cutaneous melanoma (HP:0012056) | 2.12641773 |
84 | Stomach cancer (HP:0012126) | 2.11561784 |
85 | Genetic anticipation (HP:0003743) | 2.10005200 |
86 | Thyroiditis (HP:0100646) | 2.09736151 |
87 | Abnormality of the labia minora (HP:0012880) | 2.08939020 |
88 | Mediastinal lymphadenopathy (HP:0100721) | 2.06665116 |
89 | Anorexia (HP:0002039) | 2.05905209 |
90 | Lymphoma (HP:0002665) | 2.04241124 |
91 | Proximal placement of thumb (HP:0009623) | 2.04114784 |
92 | Chest pain (HP:0100749) | 2.04012919 |
93 | Deviation of the thumb (HP:0009603) | 2.02603589 |
94 | Birth length less than 3rd percentile (HP:0003561) | 2.01263846 |
95 | Disinhibition (HP:0000734) | 2.00530114 |
96 | Eosinophilia (HP:0001880) | 2.00254844 |
97 | Abnormality of the carotid arteries (HP:0005344) | 2.00120285 |
98 | Increased IgM level (HP:0003496) | 1.99918682 |
99 | Spinal muscular atrophy (HP:0007269) | 1.99778680 |
100 | Overriding aorta (HP:0002623) | 1.99714266 |
101 | Neoplasm of the adrenal cortex (HP:0100641) | 1.99358182 |
102 | Abnormality of the pleura (HP:0002103) | 1.99252988 |
103 | Abnormality of the motor neurons (HP:0002450) | 1.98293447 |
104 | Abnormal neuron morphology (HP:0012757) | 1.98293447 |
105 | Ectopic kidney (HP:0000086) | 1.96719533 |
106 | Papilloma (HP:0012740) | 1.96658916 |
107 | Verrucae (HP:0200043) | 1.96658916 |
108 | Leukocytosis (HP:0001974) | 1.95642519 |
109 | Recurrent sinusitis (HP:0011108) | 1.95515268 |
110 | Increased serum ferritin (HP:0003281) | 1.94655520 |
111 | Prominent nose (HP:0000448) | 1.93491481 |
112 | Myelodysplasia (HP:0002863) | 1.93448926 |
113 | Insomnia (HP:0100785) | 1.91918646 |
114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90596466 |
115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90596466 |
116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90596466 |
117 | Amaurosis fugax (HP:0100576) | 1.90224050 |
118 | Epistaxis (HP:0000421) | 1.90095627 |
119 | Basal cell carcinoma (HP:0002671) | 1.89893616 |
120 | Congenital stationary night blindness (HP:0007642) | 1.88915185 |
121 | Autoimmune hemolytic anemia (HP:0001890) | 1.88484315 |
122 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87586640 |
123 | Neoplasm of the oral cavity (HP:0100649) | 1.86991037 |
124 | Medulloblastoma (HP:0002885) | 1.86345847 |
125 | Abnormality of iron homeostasis (HP:0011031) | 1.85629071 |
126 | Cutis marmorata (HP:0000965) | 1.85533917 |
127 | Loss of speech (HP:0002371) | 1.85102864 |
128 | Nasal polyposis (HP:0100582) | 1.84779958 |
129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84607501 |
130 | Keratitis (HP:0000491) | 1.84430873 |
131 | Gangrene (HP:0100758) | 1.84371725 |
132 | IgG deficiency (HP:0004315) | 1.83967584 |
133 | Cheilitis (HP:0100825) | 1.83900219 |
134 | Restrictive lung disease (HP:0002091) | 1.83516985 |
135 | Glioma (HP:0009733) | 1.83010080 |
136 | Abnormality of the endocardium (HP:0004306) | 1.82902826 |
137 | Chronic diarrhea (HP:0002028) | 1.82428692 |
138 | Selective tooth agenesis (HP:0001592) | 1.82187119 |
139 | Abnormality of chromosome stability (HP:0003220) | 1.80921973 |
140 | Polyneuropathy (HP:0001271) | 1.80881459 |
141 | Elfin facies (HP:0004428) | 1.80407105 |
142 | Macroglossia (HP:0000158) | 1.79242065 |
143 | Periodontitis (HP:0000704) | 1.79203441 |
144 | Abnormality of eosinophils (HP:0001879) | 1.78767369 |
145 | Agnosia (HP:0010524) | 1.78144351 |
146 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.76590271 |
147 | Entropion (HP:0000621) | 1.75922045 |
148 | Thoracic kyphosis (HP:0002942) | 1.75676367 |
149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.74818357 |
150 | Obstructive lung disease (HP:0006536) | 1.74818357 |
151 | Bronchitis (HP:0012387) | 1.74632545 |
152 | Alveolar cell carcinoma (HP:0006519) | 1.74198258 |
153 | Trigonocephaly (HP:0000243) | 1.73927213 |
154 | Abnormality of chromosome segregation (HP:0002916) | 1.73632963 |
155 | Long eyelashes (HP:0000527) | 1.73333996 |
156 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72960290 |
157 | Cellular immunodeficiency (HP:0005374) | 1.72738243 |
158 | Renovascular hypertension (HP:0100817) | 1.72498103 |
159 | Leukopenia (HP:0001882) | 1.71901158 |
160 | Supranuclear gaze palsy (HP:0000605) | 1.71659477 |
161 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.71410838 |
162 | Cafe-au-lait spot (HP:0000957) | 1.71408588 |
163 | Chronic otitis media (HP:0000389) | 1.70144248 |
164 | Autoimmune thrombocytopenia (HP:0001973) | 1.70107057 |
165 | Granulocytopenia (HP:0001913) | 1.70042056 |
166 | Recurrent otitis media (HP:0000403) | 1.69855268 |
167 | Pointed chin (HP:0000307) | 1.69113600 |
168 | Bone marrow hypocellularity (HP:0005528) | 1.68207775 |
169 | Optic nerve coloboma (HP:0000588) | 1.68153391 |
170 | Osteomyelitis (HP:0002754) | 1.67966146 |
171 | Long palpebral fissure (HP:0000637) | 1.67961487 |
172 | Leiomyosarcoma (HP:0100243) | 1.67712099 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 4.22426729 |
2 | MAP4K1 | 3.49817210 |
3 | TESK2 | 3.12044124 |
4 | EEF2K | 3.07572293 |
5 | FRK | 2.68199982 |
6 | RIPK4 | 2.60816184 |
7 | NEK2 | 2.48268219 |
8 | CDK12 | 2.46488668 |
9 | STK10 | 2.25823675 |
10 | KSR1 | 2.18928860 |
11 | CDC7 | 2.04982719 |
12 | SIK3 | 2.00431481 |
13 | MARK3 | 1.94887621 |
14 | TESK1 | 1.93898846 |
15 | MAP2K3 | 1.88463557 |
16 | FES | 1.86237180 |
17 | TNK2 | 1.80863005 |
18 | ICK | 1.80558272 |
19 | BRD4 | 1.72376696 |
20 | MARK1 | 1.72159336 |
21 | EPHB1 | 1.61361309 |
22 | ADRBK2 | 1.58193715 |
23 | PASK | 1.58039402 |
24 | PINK1 | 1.53000814 |
25 | IKBKB | 1.48583102 |
26 | TXK | 1.47915664 |
27 | ITK | 1.47699558 |
28 | ATR | 1.40734196 |
29 | SCYL2 | 1.38470852 |
30 | TYK2 | 1.36757430 |
31 | SIK2 | 1.36488664 |
32 | RPS6KB2 | 1.35012494 |
33 | PAK6 | 1.34986651 |
34 | TBK1 | 1.34737945 |
35 | BTK | 1.34439385 |
36 | DYRK3 | 1.31692086 |
37 | MAP3K11 | 1.28508464 |
38 | EPHA3 | 1.28041631 |
39 | FGR | 1.27399816 |
40 | TRIB3 | 1.26754552 |
41 | IRAK4 | 1.26612936 |
42 | GRK6 | 1.25904600 |
43 | NLK | 1.23780223 |
44 | MATK | 1.23696634 |
45 | ZAP70 | 1.22910171 |
46 | CDC42BPA | 1.22448387 |
47 | DYRK2 | 1.21658620 |
48 | MAP3K13 | 1.21520125 |
49 | BUB1 | 1.21232887 |
50 | DYRK1B | 1.13802521 |
51 | KIT | 1.10698334 |
52 | TEC | 1.07733825 |
53 | ERN1 | 1.06360862 |
54 | PKN2 | 1.04574453 |
55 | MAP3K8 | 1.02909829 |
56 | MARK2 | 1.02107970 |
57 | PIM1 | 1.01815824 |
58 | TLK1 | 1.01460699 |
59 | JAK3 | 1.01290125 |
60 | SYK | 1.00714247 |
61 | MAP3K14 | 1.00251400 |
62 | STK4 | 0.98253761 |
63 | BCR | 0.98094531 |
64 | MAP3K1 | 0.97326434 |
65 | MAP3K3 | 0.97062046 |
66 | RPS6KA6 | 0.95172113 |
67 | CDK4 | 0.93126249 |
68 | TTK | 0.93018871 |
69 | CLK1 | 0.92281267 |
70 | PRKCQ | 0.92230735 |
71 | PRPF4B | 0.91906459 |
72 | CAMKK2 | 0.91827783 |
73 | SGK2 | 0.90203907 |
74 | CHEK2 | 0.89529340 |
75 | BLK | 0.88724029 |
76 | CHEK1 | 0.88386594 |
77 | PDK1 | 0.87339819 |
78 | EIF2AK1 | 0.87124938 |
79 | ALK | 0.87025759 |
80 | GRK7 | 0.85969284 |
81 | DAPK2 | 0.84805393 |
82 | BMPR1B | 0.83357993 |
83 | ACVR1B | 0.81136427 |
84 | MAP3K7 | 0.81090003 |
85 | CSF1R | 0.81035607 |
86 | HCK | 0.80135336 |
87 | RPS6KC1 | 0.79450227 |
88 | RPS6KL1 | 0.79450227 |
89 | PRKD2 | 0.79427949 |
90 | HIPK2 | 0.79196599 |
91 | RPS6KA2 | 0.76588041 |
92 | PTK2B | 0.76558962 |
93 | CSNK1A1L | 0.76515324 |
94 | CAMKK1 | 0.76470523 |
95 | UHMK1 | 0.76426345 |
96 | LIMK1 | 0.76292482 |
97 | CSNK1G3 | 0.73996707 |
98 | KSR2 | 0.73630171 |
99 | PAK4 | 0.73538715 |
100 | IRAK3 | 0.73285018 |
101 | LRRK2 | 0.72606130 |
102 | MAP2K2 | 0.71854615 |
103 | CHUK | 0.71588286 |
104 | SGK223 | 0.71230608 |
105 | SGK494 | 0.71230608 |
106 | IRAK1 | 0.70181368 |
107 | CDK6 | 0.69196638 |
108 | CDK2 | 0.68658540 |
109 | PLK1 | 0.68285097 |
110 | MAPK12 | 0.67399992 |
111 | TAOK1 | 0.66468148 |
112 | PDPK1 | 0.65293076 |
113 | RAF1 | 0.64372267 |
114 | CAMK1D | 0.63979170 |
115 | PAK3 | 0.62139602 |
116 | JAK1 | 0.62082044 |
117 | SGK3 | 0.62028461 |
118 | CSNK1G2 | 0.61923594 |
119 | LCK | 0.60677563 |
120 | CSK | 0.60312444 |
121 | MAP3K9 | 0.58761352 |
122 | IRAK2 | 0.55389684 |
123 | TAOK3 | 0.55383379 |
124 | CSNK1D | 0.55070727 |
125 | CDK18 | 0.54483538 |
126 | TGFBR2 | 0.53499220 |
127 | CAMK4 | 0.53281132 |
128 | BRSK1 | 0.52564343 |
129 | MELK | 0.50957090 |
130 | RPS6KA4 | 0.50603127 |
131 | ATM | 0.50468397 |
132 | FGFR4 | 0.49458241 |
133 | DYRK1A | 0.48627392 |
134 | PTK6 | 0.47453853 |
135 | TYRO3 | 0.47404366 |
136 | TGFBR1 | 0.47288125 |
137 | WEE1 | 0.46596813 |
138 | PIK3CG | 0.46368265 |
139 | MAPK7 | 0.45729841 |
140 | STK11 | 0.44740666 |
141 | JAK2 | 0.44610435 |
142 | CDK7 | 0.44435182 |
143 | CDK1 | 0.44334405 |
144 | PDGFRB | 0.43946691 |
145 | CSNK1G1 | 0.43865171 |
146 | CDK15 | 0.43787562 |
147 | * MTOR | 0.43315549 |
148 | IKBKE | 0.43197356 |
149 | MAPK11 | 0.42993399 |
150 | FGFR3 | 0.42507039 |
151 | MAPK9 | 0.42233611 |
152 | AURKB | 0.42115831 |
153 | PRKCZ | 0.40820188 |
154 | MAP3K6 | 0.40768426 |
155 | PAK1 | 0.40739465 |
156 | ERBB3 | 0.40116897 |
157 | MAP2K6 | 0.38980632 |
158 | GRK1 | 0.38760944 |
159 | ADRBK1 | 0.38503999 |
160 | PRKCH | 0.38501676 |
161 | TRPM7 | 0.37786553 |
162 | LYN | 0.37613972 |
163 | TAOK2 | 0.32532512 |
164 | RPS6KA5 | 0.31825254 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.63928255 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.31563704 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15734579 |
4 | Asthma_Homo sapiens_hsa05310 | 2.12929990 |
5 | Base excision repair_Homo sapiens_hsa03410 | 2.05649158 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01353865 |
7 | Cell cycle_Homo sapiens_hsa04110 | 1.98007582 |
8 | DNA replication_Homo sapiens_hsa03030 | 1.94647058 |
9 | Spliceosome_Homo sapiens_hsa03040 | 1.94041991 |
10 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.90748122 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89686387 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.88622904 |
13 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84100128 |
14 | RNA transport_Homo sapiens_hsa03013 | 1.80474424 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78924535 |
16 | Mismatch repair_Homo sapiens_hsa03430 | 1.72301399 |
17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68895109 |
18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64956837 |
19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.64732272 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63501473 |
21 | Colorectal cancer_Homo sapiens_hsa05210 | 1.62303788 |
22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.57491251 |
23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55880715 |
24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54803213 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48775663 |
26 | Measles_Homo sapiens_hsa05162 | 1.43910505 |
27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43830936 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.43262711 |
29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42705697 |
30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40660341 |
31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38971888 |
32 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.34430169 |
33 | Malaria_Homo sapiens_hsa05144 | 1.33015376 |
34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.31244343 |
35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29822463 |
36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.29416596 |
37 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28975106 |
38 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.28676279 |
39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.27891518 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.26319581 |
41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.25337385 |
42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23379513 |
43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22619433 |
44 | Lysosome_Homo sapiens_hsa04142 | 1.22458780 |
45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21576756 |
46 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.19767488 |
47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17095233 |
48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17000665 |
49 | HTLV-I infection_Homo sapiens_hsa05166 | 1.16911421 |
50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14604966 |
51 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.12485080 |
52 | Hepatitis B_Homo sapiens_hsa05161 | 1.11534438 |
53 | Influenza A_Homo sapiens_hsa05164 | 1.11226214 |
54 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09194081 |
55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.08774822 |
56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07167468 |
57 | Phagosome_Homo sapiens_hsa04145 | 1.05691197 |
58 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.05125921 |
59 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.05002414 |
60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04020837 |
61 | Basal transcription factors_Homo sapiens_hsa03022 | 1.02679386 |
62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01464971 |
63 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00055277 |
64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99956586 |
65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99692891 |
66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98874231 |
67 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98581279 |
68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97635596 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.96326469 |
70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95851828 |
71 | Legionellosis_Homo sapiens_hsa05134 | 0.94701334 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94636709 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94207356 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91792733 |
75 | RNA degradation_Homo sapiens_hsa03018 | 0.91579827 |
76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91390137 |
77 | Homologous recombination_Homo sapiens_hsa03440 | 0.90230975 |
78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90168896 |
79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88458468 |
80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.84182750 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83206157 |
82 | Tuberculosis_Homo sapiens_hsa05152 | 0.78624736 |
83 | Endocytosis_Homo sapiens_hsa04144 | 0.78407403 |
84 | Salmonella infection_Homo sapiens_hsa05132 | 0.76958763 |
85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76709530 |
86 | Allograft rejection_Homo sapiens_hsa05330 | 0.76454264 |
87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75961797 |
88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75459921 |
89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75322431 |
90 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75295190 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70689420 |
92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64484648 |
93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64178911 |
94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63614340 |
95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63363374 |
96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62738191 |
97 | Phototransduction_Homo sapiens_hsa04744 | 0.61736741 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60083779 |
99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59892924 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59178176 |
101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59162841 |
102 | Adherens junction_Homo sapiens_hsa04520 | 0.59112827 |
103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58529455 |
104 | Hepatitis C_Homo sapiens_hsa05160 | 0.58523623 |
105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58505444 |
106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58058529 |
107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57751719 |
108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57277046 |
109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57042752 |
110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56949007 |
111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56551686 |
112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56270643 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55145819 |
114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53772094 |
115 | Prostate cancer_Homo sapiens_hsa05215 | 0.53288060 |
116 | ABC transporters_Homo sapiens_hsa02010 | 0.52921167 |
117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52853843 |
118 | Lysine degradation_Homo sapiens_hsa00310 | 0.52746311 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51546424 |
120 | Platelet activation_Homo sapiens_hsa04611 | 0.51495621 |
121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51381689 |
122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50651650 |
123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49750241 |
124 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49464639 |
125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48843328 |
126 | Alcoholism_Homo sapiens_hsa05034 | 0.48742648 |
127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48553143 |
128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48186675 |
129 | Insulin resistance_Homo sapiens_hsa04931 | 0.47468850 |
130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46616744 |
131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46247357 |
132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46147084 |
133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45781383 |
134 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45582096 |
135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45153857 |
136 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44673534 |
137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43160512 |
138 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42099877 |
139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41313132 |
140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40935953 |
141 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40449629 |
142 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37093645 |
143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36799765 |